Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164
ropinirole
101468/196
NCT00650104
Parkinson Disease
Phase 3
 
This is a follow-up study to 101468/164 and 101468/167.
June 2014

Powered by ideaPoint, Inc.